ATE164853T1 - Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids - Google Patents

Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids

Info

Publication number
ATE164853T1
ATE164853T1 AT91400049T AT91400049T ATE164853T1 AT E164853 T1 ATE164853 T1 AT E164853T1 AT 91400049 T AT91400049 T AT 91400049T AT 91400049 T AT91400049 T AT 91400049T AT E164853 T1 ATE164853 T1 AT E164853T1
Authority
AT
Austria
Prior art keywords
leu
gln
cys
ile
gly
Prior art date
Application number
AT91400049T
Other languages
English (en)
Inventor
Jacques Martin
Gerard Somme
Original Assignee
Orgenics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9000456A external-priority patent/FR2657017B1/fr
Priority claimed from FR9000455A external-priority patent/FR2657016B1/fr
Application filed by Orgenics Ltd filed Critical Orgenics Ltd
Application granted granted Critical
Publication of ATE164853T1 publication Critical patent/ATE164853T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT91400049T 1990-01-16 1991-01-11 Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids ATE164853T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9000456A FR2657017B1 (fr) 1990-01-16 1990-01-16 Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
FR9000455A FR2657016B1 (fr) 1990-01-16 1990-01-16 Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.

Publications (1)

Publication Number Publication Date
ATE164853T1 true ATE164853T1 (de) 1998-04-15

Family

ID=26227799

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91400049T ATE164853T1 (de) 1990-01-16 1991-01-11 Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids

Country Status (5)

Country Link
US (1) US5480966A (de)
EP (1) EP0438332B1 (de)
JP (1) JP3020289B2 (de)
AT (1) ATE164853T1 (de)
DE (1) DE69129207T2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544728B1 (en) * 1986-01-22 2003-04-08 Institut Pasteur Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US6514691B1 (en) 1986-01-22 2003-02-04 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
US6054565A (en) 1986-03-03 2000-04-25 Institut Pasteur Nucleic Acids of HIV-2, Diagnostic Test Kit and Method using Nucleic Acid Probes of HIV-2
DE4032127A1 (de) * 1990-10-10 1992-04-16 Basf Ag Verwendung von disulfidverbrueckten proteinen und peptiden
US5811246A (en) * 1991-12-17 1998-09-22 The Research Foundation Of State University Of New York Process for immobilization onto the surfaces of ELISA plates of a compound carrier complex and for immunization
ES2287969T3 (es) 1992-03-06 2007-12-16 Innogenetics N.V. Peptidos de vih.
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
WO1996003651A1 (de) * 1994-07-25 1996-02-08 Boehringer Mannheim Gmbh Metallchelat-markierte peptide
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525592B1 (de) * 1982-04-26 1984-09-14 Pasteur Institut
US4768607A (en) * 1983-06-09 1988-09-06 Molina Antonio F Freewheel flywheel transmission system
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
KR910002374B1 (ko) * 1985-04-29 1991-04-20 제네틱 시스템즈 코포레이션 Aids 관련질병의 검출을 위한 합성항원
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
NZ219024A (en) * 1986-01-22 1990-04-26 Pasteur Institut Hiv-2 retrovirus protein and nucleic acid sequences and detection methods
ATE98376T1 (de) * 1986-03-24 1993-12-15 Ortho Pharma Corp Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4957737A (en) * 1986-05-27 1990-09-18 Hoffmann-La Roche Inc. HTLV-III (LAV) envelope peptides
EP0247557B1 (de) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag HTLV-III(LAV)Decke-Peptide
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
ES2104556T3 (es) * 1987-01-16 1997-10-16 Pasteur Institut Peptidos que tienen propiedades inmunologicas de hiv-2.
ATE108457T1 (de) * 1987-03-25 1994-07-15 Genetic Systems Corp Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
EP0309566B1 (de) * 1987-04-16 1994-01-12 Johnson And Johnson Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
US5338829A (en) * 1988-04-20 1994-08-16 Trustees Of The University Of Pennsylvania Peptides derived from human immunodeficiency virus-1 GP160
US5260189A (en) * 1988-12-20 1993-11-09 Immunodiagnostics, Inc. Synthetic HIV-like peptides their compositions and uses
DE69013950T2 (de) * 1989-02-03 1995-03-30 Abbott Lab Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
DE69032009T2 (de) * 1989-06-02 1998-07-23 Genetic Systems Corp., Seattle, Wash. Peptide mit thiolgeschütztem cystein zur verwendung in immuntests
US5283320A (en) * 1989-11-13 1994-02-01 Syntello Ab Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom

Also Published As

Publication number Publication date
JPH04210999A (ja) 1992-08-03
JP3020289B2 (ja) 2000-03-15
DE69129207T2 (de) 1998-10-08
US5480966A (en) 1996-01-02
DE69129207D1 (de) 1998-05-14
EP0438332B1 (de) 1998-04-08
EP0438332A1 (de) 1991-07-24

Similar Documents

Publication Publication Date Title
DE69129207D1 (de) Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
DE69125925D1 (de) Rekombinante herpes simplex virus impfstoffe und methoden
DE3852665D1 (de) Säurebeständige Dideoxynucleoside, wirksam gegen den HIV-Virus.
TR24925A (tr) (benzilidin)-azolimetilsikloalkan ve fungisid olarak kullanilmasi
ATE236262T1 (de) Rekombinanter schweinepocken-virus
ATE188220T1 (de) Asiloglycoproteine des hepatitis c-virus
GR900100459A (el) Ζιζανιοκτονες συνθεσεις με βαση ν-φωσφονομεθυλογλυκινη και η χρησιμοποιηση τους.
KR910700089A (ko) 히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
ES2062805T3 (es) Procedimiento para la preparacion de sulfatos ciclicos.
DK0593487T3 (da) Vandigt autoxidativt tørrende alkydpræparat
DE69323130D1 (de) Avirulenter Tollwut-Impfstoff
ATE96326T1 (de) Hemmung der in-vitro-infektivitaet und des zytopathischen effektes von htlv-iii/lav durch 2'3'-dideoxycytidin.
IL88963A0 (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
OA09653A (en) Rubella peptides
ATE123523T1 (de) Expression von hiv1- und 2- polypeptiden und deren verwendung.
DE59100308D1 (de) Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren.
ES2087199T3 (es) Vacunas contra virus de herpes equino y su fabricacion.
NO933269L (no) Polypeptider avledet fra humanimmunsviktvirusets endonukleaseprotein
DE69028953D1 (de) Antiherpes-Pentapeptide
DE68925191D1 (de) Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen
ES2165840T3 (es) Vacunas para la hepatitis a.
DE68905875D1 (de) Anti-hiv-wirkung von bu-3608.
ES2084587T3 (es) Arn virus no revertientes.
DE69936464D1 (de) Gp120-mutanten und deren biologische verwendungen
ATE46264T1 (de) Thymidinkinase-negativ-temperaturbestaendiger rinder herpes-virus-1-mutant als vakzin gegen infektioese rinder-rhinotracheitis.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties